Teriflunomide May Delay Onset of MS Symptoms in People With RIS
A recent Phase 3 trial showed people with radiologically isolated syndrome (RIS) who took Aubagio were 72 percent less likely to later develop MS symptoms.
Source: everydayhealth.com
Systematically Screen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Systematically Screen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Systematically Screen Today - Breaking & Trending Today